Cargando…

Combination RSL3 Treatment Sensitizes Ferroptosis- and EGFR-Inhibition-Resistant HNSCCs to Cetuximab

Head and neck squamous cell carcinomas (HNSCCs) are a type of cancer originating in the mucosal epithelium of the mouth, pharynx, and larynx, the sixth most common cancer in the world. However, there is no effective treatment for HNSCCs. More than 90% of HNSCCs overexpress epidermal growth factor re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Shujie, Yan, Shuai, Zhu, Jie, Lu, Ruiqing, Kang, Chujie, Tang, Kang, Zeng, Jinfeng, Ding, Mingmei, Guo, Zixiang, Lai, Xianxin, Jiang, Yinan, Wu, Siqing, Zhou, Lihua, Sun, Litao, Zhou, Zhong-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409433/ https://www.ncbi.nlm.nih.gov/pubmed/36012290 http://dx.doi.org/10.3390/ijms23169014

Ejemplares similares

A Shortage of FTH Induces ROS and Sensitizes RAS-Proficient Neuroblastoma N2A Cells to Ferroptosis
por: Lu, Ruiqing, et al.
Publicado: (2021)

Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer
por: Yang, Jiawen, et al.
Publicado: (2021)

The Potential microRNA Prognostic Signature in HNSCCs: A Systematic Review
por: Dioguardi, Mario, et al.
Publicado: (2023)

RSL3 Inhibits Porcine Epidemic Diarrhea Virus Replication by Activating Ferroptosis
por: Li, Yingguang, et al.
Publicado: (2023)

Lipoxygenase‐mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3
por: Shintoku, Ryosuke, et al.
Publicado: (2017)

The ferroptosis inducer RSL3 triggers interictal epileptiform activity in mice cortical neurons
por: Giustizieri, Michela, et al.
Publicado: (2023)

Evaluation of the Combined Effect of Artemisinin and Ferroptosis Inducer RSL3 against Toxoplasma gondii
por: Huang, Mao, et al.
Publicado: (2022)

Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis
por: Knitz, Michael W, et al.
Publicado: (2021)

RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer
por: Sui, Xinbing, et al.
Publicado: (2018)

Le RSL au CERN
Publicado: (1998)

The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1
por: Cheff, Dorian M., et al.
Publicado: (2023)

Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancer
por: Park, Soon Young, et al.
Publicado: (2023)

Platelet-Vesicles-Encapsulated RSL-3 Enable Anti-Angiogenesis and Induce Ferroptosis to Inhibit Pancreatic Cancer Progress
por: Zhang, Yiyin, et al.
Publicado: (2022)

RSL3 Drives Ferroptosis through NF-κB Pathway Activation and GPX4 Depletion in Glioblastoma
por: Li, Shengbiao, et al.
Publicado: (2021)

Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer
por: Maccarinelli, Federica, et al.
Publicado: (2023)

GPX4 overexpressed non-small cell lung cancer cells are sensitive to RSL3-induced ferroptosis
por: Kim, Joo-Won, et al.
Publicado: (2023)

Microglia and macrophage exhibit attenuated inflammatory response and ferroptosis resistance after RSL3 stimulation via increasing Nrf2 expression
por: Cui, Yu, et al.
Publicado: (2021)

O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP/TFRC pathway in liver cancer
por: Zhu, Guoqing, et al.
Publicado: (2021)

Epithelial Membrane Protein 1 Promotes Sensitivity to RSL3-Induced Ferroptosis and Intensifies Gefitinib Resistance in Head and Neck Cancer
por: Wang, Ying, et al.
Publicado: (2022)

The RSL3 Induction of KLK Lung Adenocarcinoma Cell Ferroptosis by Inhibition of USP11 Activity and the NRF2-GSH Axis
por: Zhang, Wenlong, et al.
Publicado: (2022)

Novel roles for HMGA2 isoforms in regulating oxidative stress and sensitizing to RSL3-Induced ferroptosis in prostate cancer cells
por: Campbell, Taaliah, et al.
Publicado: (2023)

Low-Concentration PTX And RSL3 Inhibits Tumor Cell Growth Synergistically By Inducing Ferroptosis In Mutant p53 Hypopharyngeal Squamous Carcinoma
por: Ye, Jing, et al.
Publicado: (2019)

Structural and Biochemical Bases for the Redox Sensitivity of Mycobacterium tuberculosis RslA
por: Thakur, Krishan Gopal, et al.
Publicado: (2010)

L-F001, a Multifunctional Fasudil-Lipoic Acid Dimer Prevents RSL3-Induced Ferroptosis via Maintaining Iron Homeostasis and Inhibiting JNK in HT22 Cells
por: Peng, Weijia, et al.
Publicado: (2022)

RSL1D1 promotes the progression of colorectal cancer through RAN-mediated autophagy suppression
por: Liu, Xunhua, et al.
Publicado: (2022)

Aspirin promotes RSL3-induced ferroptosis by suppressing mTOR/SREBP-1/SCD1-mediated lipogenesis in PIK3CA-mutatnt colorectal cancer
por: Chen, Hao, et al.
Publicado: (2022)

Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy (†)
por: Sihver, Wiebke, et al.
Publicado: (2014)

Engineering an Enhanced EGFR Engager: Humanization of Cetuximab for Improved Developability
por: Goulet, Dennis R., et al.
Publicado: (2022)

Non-Lethal Doses of RSL3 Impair Microvascular Endothelial Barrier through Degradation of Sphingosie-1-Phosphate Receptor 1 and Cytoskeletal Arrangement in A Ferroptosis-Independent Manner
por: Baoyinna, Boina, et al.
Publicado: (2023)

EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab
por: CHIADINI, ELISA, et al.
Publicado: (2015)

RSL Class I Genes Controlled the Development of Epidermal Structures in the Common Ancestor of Land Plants
por: Proust, Hélène, et al.
Publicado: (2016)

Advanced malignancies treated with a combination of the VEGF inhibitor bevacizumab, anti-EGFR antibody cetuximab, and the mTOR inhibitor temsirolimus
por: Liu, Xiaochun, et al.
Publicado: (2016)

PHLDB2 Mediates Cetuximab Resistance via Interacting With EGFR in Latent Metastasis of Colorectal Cancer
por: Luo, Maochao, et al.
Publicado: (2021)

A Novel EGFR Targeted Immunotoxin Based on Cetuximab and Type 1 RIP Quinoin Overcomes the Cetuximab Resistance in Colorectal Cancer Cells
por: Landi, Nicola, et al.
Publicado: (2023)

RSL3 and Erastin differentially regulate redox signaling to promote Smac mimetic-induced cell death
por: Dächert, Jasmin, et al.
Publicado: (2016)

Combination of afatinib with cetuximab in patients with EGFR-mutant non-small-cell lung cancer resistant to EGFR inhibitors
por: Ribeiro Gomes, Jéssica, et al.
Publicado: (2015)

Anti-EGFR antibody 528 binds to domain III of EGFR at a site shifted from the cetuximab epitope
por: Makabe, Koki, et al.
Publicado: (2021)

Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients
por: Cappuzzo, F, et al.
Publicado: (2008)

Antitumor effect of cetuximab in combination with S-1 in EGFR-amplified gastric cancer cells
por: FUKUDA, KAZUMASA, et al.
Publicado: (2011)

A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy
por: Zhang, Lianhai, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g5qa9on1lf3dkuo00us0k1r6t8